100.20

0.41% 0.41

Pre-market: 99.75 -0.45 -0.45%

Crh Plc (CRH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Crh Plc stock is traded at $100.20, with a volume of 2.68M. It is up +0.41% in the last 24 hours and up +7.19% over the past month. CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.

Previous Close:

$99.79

Open:

$100.03

24h Volume:

2.68M

Relative Volume:

0.73

Market Cap:

$68.01B

Revenue:

$35.39B

Net Income/Loss:

$3.49B

P/E Ratio:

25.82

EPS:

3.88

Net Cash Flow:

$2.41B

1W Performance:

+1.03%

1M Performance:

+7.19%

6M Performance:

+22.42%

1Y Performance:

+70.58%

1-Day Range:

$99.34

$100.38

1-Week Range:

$97.55

$100.83

52-Week Range:

$59.98

$102.51

Crh Plc Stock (CRH) Company Profile

Name

Crh Plc

Sector

Basic Materials (270)

Industry

Building Materials (16)

Phone

353 1 404 1000

Address

STONEMASON'S WAY, RATHFARNHAM, DUBLIN 16

Employee

78,500

Twitter

@CRH_Americas

Next Earnings Date

2024-11-07

Latest SEC Filings

CRH's Discussions on Twitter

Compare CRH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRH	100.20	68.01B	35.39B	3.49B	2.41B	3.88
VMC	277.81	36.69B	7.40B	845.70M	803.80M	6.17
MLM	585.26	35.53B	6.51B	1.98B	520.10M	17.23
JHX	35.38	15.19B	3.97B	507.70M	393.50M	1.14
EXP	300.27	10.07B	2.27B	483.60M	462.54M	13.65

Crh Plc Stock (CRH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-18-24	Initiated	Stephens	Overweight
May-14-24	Initiated	RBC Capital Mkts	Outperform
Apr-15-24	Downgrade	Stifel	Buy → Hold
Mar-22-24	Initiated	Vertical Research	Buy
Jan-19-24	Initiated	DA Davidson	Buy
Dec-14-23	Initiated	Truist	Buy
Nov-06-23	Initiated	Goldman	Neutral
Aug-22-23	Resumed	Citigroup	Buy
Jun-15-23	Resumed	Redburn	Buy
Jan-03-23	Upgrade	Redburn	Neutral → Buy
Jun-17-22	Resumed	Citigroup	Buy
Apr-19-22	Upgrade	Barclays	Equal Weight → Overweight
Mar-22-22	Downgrade	Redburn	Buy → Neutral
Jun-25-21	Upgrade	Berenberg	Hold → Buy
Jun-14-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-12-21	Upgrade	Citigroup	Neutral → Buy
Nov-18-20	Initiated	Deutsche Bank	Buy
Jul-02-20	Upgrade	Credit Suisse	Neutral → Outperform
Jun-22-20	Downgrade	Societe Generale	Buy → Hold
Dec-16-19	Downgrade	Barclays	Equal Weight → Underweight
Nov-20-19	Downgrade	Kepler	Hold → Reduce
Sep-05-19	Upgrade	Deutsche Bank	Hold → Buy
Sep-05-19	Downgrade	Goldman	Buy → Neutral
Jul-08-19	Downgrade	Barclays	Overweight → Equal Weight
Apr-03-19	Resumed	Berenberg	Buy
Feb-26-19	Initiated	Credit Suisse	Neutral
Jan-23-19	Upgrade	Exane BNP Paribas	Neutral → Outperform
Nov-14-18	Downgrade	Exane BNP Paribas	Outperform → Neutral
Mar-14-18	Upgrade	Exane BNP Paribas	Neutral → Outperform
Mar-12-18	Initiated	Goldman	Buy
Sep-27-17	Initiated	Jefferies	Buy
Sep-13-17	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Apr-21-17	Upgrade	BofA/Merrill	Neutral → Buy
Jan-31-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-20-16	Upgrade	Societe Generale	Hold → Buy
Aug-26-16	Downgrade	Societe Generale	Buy → Hold